About this trial
The aim of the present study is to test the accuracy and reliability of AI tools in this regard by interpreting NIRS, which we routinely use for monitoring cerebral perfusion in cardiovascular surgery, with AI tools and comparing this interpretation with the interpretations of two clinicians.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
open cardiac surgery
elective open heart surgery
aged 18-65
ASA score I-III
Disqualifiers
past ischemic event
carotid arter stenosis
BMI >30 kg/m2
serious liver or kidney disease
Trial population
Patients aged 18-65 years with ASA scores I-III and BMI \<30 kg/m2 who are scheduled for elective open heart surgery will be included.
Trial design
Other
Prospective
Treatments tested in this trial
CHATGPT GROUP
Other interventionCHATGPT responses
GEMINI GROUP
Other interventionGEMINI responses
COPILOT GROUP
Other interventionCOPILOT responses
CLINICIAN GROUP
Other interventionCLINICIAN responses
Treatment groups
Trial outcomes
Primary outcomes
Clinical Experience
The proximity of AI programs to the clinical experience
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: